Home > Insider Trading > Filing (0001209191-20-055421)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1819790	Tarsus Pharmaceuticals Inc.	TARS	Biological Products, (No Disgnostic Substances) (2836)	814717861

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1827272	E. Jason Tester	C/Otarsus Pharmaceuticals, Inc. 15440 Laguna Canyon Road, Suite 160 Irvine CA 92618		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-10-20	21,575	$0.00	21,575	No	4	C	Indirect	By Tester Living Trust
Common Stock	Acquisiton	2020-10-20	3,698	$0.00	25,273	No	4	C	Indirect	By Tester Living Trust
Common Stock	Acquisiton	2020-10-20	3,125	$16.00	28,398	No	4	P	Indirect	By Tester Living Trust
Common Stock	Acquisiton	2020-10-20	1,434,790	$0.00	1,434,790	No	4	C	Indirect	By Horowitz Limited Partnership VIII
Common Stock	Acquisiton	2020-10-20	245,966	$0.00	1,680,756	No	4	C	Indirect	By Horowitz Limited Partnership VIII
Common Stock	Acquisiton	2020-10-20	71,427	$0.00	1,752,183	No	4	C	Indirect	By Horowitz Limited Partnership VIII
Common Stock	Acquisiton	2020-10-20	168,750	$16.00	1,920,933	No	4	P	Indirect	By Horowitz Limited Partnership VIII

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By Tester Living Trust
No	4	C	Indirect	By Tester Living Trust
No	4	P	Indirect	By Tester Living Trust
No	4	C	Indirect	By Horowitz Limited Partnership VIII
No	4	C	Indirect	By Horowitz Limited Partnership VIII
No	4	C	Indirect	By Horowitz Limited Partnership VIII
No	4	P	Indirect	By Horowitz Limited Partnership VIII

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2020-10-20	21,575	$0.00	21,575	$0.00
Common Stock	Series B Preferred Stock	Disposition	2020-10-20	3,698	$0.00	3,698	$0.00
Common Stock	Series A Preferred Stock	Disposition	2020-10-20	1,434,790	$0.00	1,434,790	$0.00
Common Stock	Series B Preferred Stock	Disposition	2020-10-20	245,966	$0.00	245,966	$0.00
Common Stock	Series C Preferred Stock	Disposition	2020-10-20	71,427	$0.00	71,427	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Immediately prior to the closing of the Issuer's initial public offering, each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into shares of the Issuer's common stock, par value $0.0001 per share, on a one-for-one basis. The shares of Preferred Stock had no expiration date.
The Reporting Person is the trustee of the Tester Living Trust, and has voting and dispositive power with respect to these shares.
The shares are held directly by Horowitz Limited Partnership VIII. The Reporting Person is the Chief Financial Officer of Horowitz Management, Inc., the managing partner of Horowitz Limited Partnership VIII. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.